IT1244507B - Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti - Google Patents

Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Info

Publication number
IT1244507B
IT1244507B ITRM910246A ITRM910246A IT1244507B IT 1244507 B IT1244507 B IT 1244507B IT RM910246 A ITRM910246 A IT RM910246A IT RM910246 A ITRM910246 A IT RM910246A IT 1244507 B IT1244507 B IT 1244507B
Authority
IT
Italy
Prior art keywords
compounds
memory
pharmaceutical compositions
acid derivatives
activators
Prior art date
Application number
ITRM910246A
Other languages
English (en)
Inventor
Fabio Giannessi
Orlando Ghirardi
Roberto Cozzolino
Domenico Misiti
Maria Ornella Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to ITRM910246A priority Critical patent/IT1244507B/it
Publication of ITRM910246A0 publication Critical patent/ITRM910246A0/it
Priority to US07/864,688 priority patent/US5227496A/en
Priority to EP19920830175 priority patent/EP0511943A3/en
Priority to JP4090851A priority patent/JPH05117232A/ja
Publication of ITRM910246A1 publication Critical patent/ITRM910246A1/it
Application granted granted Critical
Publication of IT1244507B publication Critical patent/IT1244507B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Derivati dell'acido piroglutammico di formula generale (I) in cui R è scelto tra 2-(N,N-diisopropil)amminoetil, 2-amminoetil, 2-N-[(pirrolidin-2-one-l-il)] acetilamminoetil, 2-feniletil, benzil, 2-N-(piroglutamilglicil)amminoetil, 2-N-(piroglutamil)amminoetil; Y è un legame semplice fra C e N oppure è il residuo bivalente di un amminoacido sono potenti attivatori della memoria e dei processi di apprendimento. Composizioni farmaceutiche somministrabili per via orale o parenterale in forma di dosaggio unitario, comprendono da circa 100 a circa 500 mg di uno dei composti di formula (I).
ITRM910246A 1991-04-11 1991-04-11 Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti IT1244507B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITRM910246A IT1244507B (it) 1991-04-11 1991-04-11 Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US07/864,688 US5227496A (en) 1991-04-11 1992-04-07 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same
EP19920830175 EP0511943A3 (en) 1991-04-11 1992-04-10 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same
JP4090851A JPH05117232A (ja) 1991-04-11 1992-04-10 ピログルタミン酸誘導体および医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910246A IT1244507B (it) 1991-04-11 1991-04-11 Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Publications (3)

Publication Number Publication Date
ITRM910246A0 ITRM910246A0 (it) 1991-04-11
ITRM910246A1 ITRM910246A1 (it) 1992-10-11
IT1244507B true IT1244507B (it) 1994-07-15

Family

ID=11400081

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910246A IT1244507B (it) 1991-04-11 1991-04-11 Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Country Status (4)

Country Link
US (1) US5227496A (it)
EP (1) EP0511943A3 (it)
JP (1) JPH05117232A (it)
IT (1) IT1244507B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
CA2750577A1 (en) * 2008-12-03 2010-06-10 Presidio Pharmaceuticals, Inc. Inhibitors of hcv ns5a
CN102481291B (zh) 2009-06-25 2015-10-21 阿尔考布拉有限公司 用于治疗、减轻症状、缓解、改善和预防认知疾病、障碍或病症的方法
PL2758371T3 (pl) * 2011-09-19 2017-01-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Nowe tiopochodne niosące laktamy jako silne inhibitory hdac i ich zastosowania jako leki

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2651639A (en) * 1951-08-22 1953-09-08 American Cyanamid Co 2-pyrrolidone-5-carboxamide derivatives and methods of preparing the same
US3051722A (en) * 1960-10-21 1962-08-28 Lakeside Lab Inc 5-pyrrolidone-2-carboxamides
US4452989A (en) * 1982-06-01 1984-06-05 Charles Of The Ritz Group Ltd. Substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same
FR2597100A1 (fr) * 1986-01-21 1987-10-16 Nippon Shinyaku Co Ltd Derives du pyroglutamide
JPH0699307B2 (ja) * 1987-08-20 1994-12-07 キッセイ薬品工業株式会社 抗痴呆剤
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use

Also Published As

Publication number Publication date
JPH05117232A (ja) 1993-05-14
US5227496A (en) 1993-07-13
EP0511943A2 (en) 1992-11-04
ITRM910246A0 (it) 1991-04-11
ITRM910246A1 (it) 1992-10-11
EP0511943A3 (en) 1992-12-09

Similar Documents

Publication Publication Date Title
ES2226004T3 (es) 2-cianopirrolidinas n-sustituidas.
TWI254045B (en) 1,4-Benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, for their preparation, pharmaceuticals comprising these compounds, and their use
ZA918893B (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,process for their production and pharmaceutical agents containing these derivatives
NO944162L (no) Substituerte heterosykliske karboksylsyreamider, deres fremstilling og deres anvendelse som legemiddel
AU2002366811A1 (en) Pyrimidine a2b selective antagonist compounds, their synthesis and use
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
JP5436462B2 (ja) ピペラジン誘導体及び使用方法
NO941677D0 (no) Tetrazolderivater av gallesyrer, fremgangsmåter for fremstilling og deres anvendelse som legemiddel
IS6275A (is) Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
JPH04230369A (ja) イミダゾールの新規な硫黄誘導体、その製造方法、得られる新規な中間体、薬物としてのその使用、及びそれを含有する医薬組成物
GR3018472T3 (en) 1-Naphthyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them.
NO20045452L (no) Anvendelse av substituerte cyanopyrrolidiner og kombinasjonspreparater inneholdende disse for behandling av hyperlipidemi og assosierte sykdommer
IT1244507B (it) Derivati dell'acido piroglutammico quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
ES2311847T3 (es) Nuevos derivados de imidazoles, su prepracion y su utilizacion como medicamento.
DK0597102T3 (da) Nyt bisheterocyklisk derivat og salt heraf samt hypoglykæmisk sammensætning
IL63381A0 (en) 5-substituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-one derivatives,their preparation and pharmaceutical compositions containing them
IT1256320B (it) Derivati eterociclici
GB1564327A (en) Indazole derivates
IT1265077B1 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
IL163344A (en) 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid derivative compounds, process for their synthesis and compositions comprising the compounds as the active ingredient
DE3876711D1 (de) Piperidin-derivate, deren herstellung und deren verwendung als heilmittel.
NO20014127L (no) 5-HT1F agonister
IT1247697B (it) Composizioni farmaceutiche comprendenti 3-ammino-e-caprolattami per il potenziamento dei processi di apprendimento e della memoria.
DE59206593D1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
DK279988A (da) Spiro(4,5)decanderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960307